";s:4:"text";s:5366:" Treatment for chronic hepatitis B also requires regular medical evaluations and monitoring to determine if the virus is responding to treatment. Unfortunately, this is common in some parts of the world such as in Southeast Asia, China, and sub-Saharan Africa, where as many as 1 in 10 people have chronic hepatitis B … Because this treatment only provides short-term protection, you also should get the hepatitis B vaccine at the same time, if you never received it.If your doctor determines your hepatitis B infection is acute — meaning it is short-lived and will go away on its own — you may not need treatment.
Chronic hepatitis B — Chronic hepatitis B develops more commonly in people who are infected with the virus at an early age (often at birth). The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment.” Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment…
Doctors who specialize in treating hepatitis B include:Here's some information to help you get ready for your appointment.Listing questions for your doctor can help you make the most of your time together. It is estimated that about 780,000 people die each year due to consequences of hepatitis B… 2016 Jan;63(1):261–83. This site addresses the diagnosis, monitoring, management, and prevention of hepatitis B virus infection.
Risk for chronic infection is related to age at infection: about 90% of infants with hepatitis B go on to develop chronic infection, whereas only 2%–6% of people who get hepatitis B as adults become chronically infected. An injection of immunoglobulin (an antibody) given within 12 hours of exposure to the virus may help protect you from getting sick with hepatitis B. An injection of immunoglobulin (an antibody) given within 12 hours of exposure to the virus may help protect you from getting sick with hepatitis B.
However, in some cases, you may be referred immediately to a specialist.
Treatment for chronic hepatitis B may include:Other drugs to treat hepatitis B are being developed.If you've been infected with hepatitis B, take steps to protect others from the virus.If you've been diagnosed with hepatitis B infection, the following suggestions might help you cope:You're likely to start by seeing your family doctor or a general practitioner. In severe cases, antiviral drugs or a hospital stay is needed to prevent complications.Most people diagnosed with chronic hepatitis B infection need treatment for the rest of their lives.
These are the first World Health Organization (WHO) guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar recently published guidance by WHO on the prevention, care and treatment of infection due to the hepatitis C virus (HCV). Instead, your doctor might recommend rest, proper nutrition and plenty of fluids while your body fights the infection.
"Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research. The best way to prevent hepatitis B is to get vaccinated. Hepatitis B treatment works by stopping the hepatitis B virus from multiplying, or slowing it down as much as possible. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. It is a major global health problem, and the most serious type of viral hepatitis. Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance Norah A. Terrault,1 Anna S.F. All rights reserved. Advertising revenue supports our not-for-profit mission.Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. Contains non-binding recommendations.The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment.” The purpose of this guidance is to assist sponsors in the clinical development of drugs and biologics for the treatment of chronic hepatitis B virus (HBV) infection from the initial investigational new drug application (IND) through the new drug application (NDA)/biologics license application (BLA) and postmarketing phases.You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))If unable to submit comments online, please mail written comments to: Treatment helps reduce the risk of liver disease and prevents you from passing the infection to others.